Saturday, August 2, 2014

CDC: HAN 364: Guidelines for Evaluation of US Patients Suspected of Having Ebola Virus Disease

HAN 364 is now available at http://emergency.cdc.gov/han/han00364.asp
 Health Alert Network logo.
                                               This an official
CDC HEALTH ADVISORY

Distributed via the CDC Health Alert Network
August 1, 2014 20:00 ET (8:00 PM ET)
CDCHAN-00364
Summary
The Centers for Disease Control and Prevention (CDC) continues to work closely with the World Health Organization (WHO) and other partners to better understand and manage the public health risks posed by Ebola Virus Disease (EVD). 
To date, no cases have been reported in the United States. The purpose of this health update is 
    1) to provide updated guidance to healthcare providers and state and local health departments regarding who should be suspected of having EVD, 
    2) to clarify which specimens should be obtained and how to submit for diagnostic testing, and 
    3) to provide hospital infection control guidelines.
                                                                                                                      
U.S. hospitals can safely manage a patient with EVD by following recommended isolation and infection control procedures.

Please disseminate this information to infectious disease specialists, intensive care physicians, primary care physicians, hospital epidemiologists, infection control professionals, and hospital administration, as well as to emergency departments and microbiology laboratories.
Background
CDC is working with the World Health Organization (WHO), the ministries of health of Guinea, Liberia, and Sierra Leone, and other international organizations in response to an outbreak of EVD in West Africa, which was first reported in late March 2014. As of July 27, 2014, according to WHO, a total of 1,323 cases and 729 deaths (case fatality 55-60%) had been reported across the three affected countries. This is the largest outbreak of EVD ever documented and the first recorded in West Africa.

EVD is characterized by sudden onset of fever and malaise, accompanied by other nonspecific signs and symptoms, such as myalgia, headache, vomiting, and diarrhea. Patients with severe forms of the disease may develop hemorrhagic symptoms and multi-organ dysfunction, including hepatic damage, renal failure, and central nervous system involvement, leading to shock and death.

The fatality rate can vary from 40-90%.

In outbreak settings, Ebola virus is typically first spread to humans after contact with infected wildlife and is then spread person-to-person through direct contact with bodily fluids such as, but not limited to, blood, urine, sweat, semen, and breast milk. The incubation period is usually 8–10 days (ranges from 2–21 days). Patients can transmit the virus while febrile and through later stages of disease, as well as postmortem, when persons touch the body during funeral preparations.

<<<  continued  >>>



Black Emergency Managers Association  
We Support the GC

1231  Good Hope Road  S.E.

Washington, D.C.  20020

Office:   202-618-9097 

bEMA 

“Our lives are not our own. We are bound to others, past and present, and by each crime and every kindness, we birth our future.” ― David Mitchell, Cloud Atlas












Tuesday, July 29, 2014

FREE Webinar with CEU credits: Death in the Suburbs: How Heroin has Changed the Science and Solutions for Addiction Treatment and Recovery

The Florida Department of Children and Families (DCF) Substance Abuse and Mental Health Program Office (SAMH), in conjunction with the Florida Alcohol and Drug Abuse Association (FADAA), would like to invite you to a FREE webinar. Approximately 2.0 CEUs are available at no cost.  
WHAT:
Death in the Suburbs:  How Heroin has Changed the Science and Solutions for Addiction Treatment and Recovery 
PRESENTER:
Marvin D. Seppala, M.D.
Chief Medical Officer, Hazelden
DATE:
Friday, August 15, 2014                                          
1:00 pm - 3:00 pm (EST)      
CEUs:
Approximately 2.0 Continuing Education Units/Contact Hours are provided for this webinar
Florida Certification Board Provider #A-001, Exp. 12/31/2014
Florida Board of Social Work, Marriage and Family Therapy and Mental Health Counseling Provider #50-676, Exp.  Date 3/31/2015
Florida Board of Nursing Provider #50-676, Exp. Date 10/31/2016
WHO SHOULD ATTEND:
Clinical supervisors, program managers and executives in substance abuse, mental health, prevention agencies, community coalitions and managing entities.
ABOUT THIS WEBINAR:
Addiction to opioids like prescription painkillers and heroin has reached epidemic proportions in this country:
  • The number of people addicted to a pain reliever climbed from 1.4 million in 2004 to 2.1 million in 2012, according to the most recent National Survey on Drug Use & Health (NSDUH)
  • Deaths from drug overdose, driven by the increase in prescription painkiller abuse, now outnumber those caused by car accidents
  • Treatment admissions for prescription opioid dependence have increased at least fivefold since the mid-nineties 
In this webinar, Marvin Seppala, M.D., the chief medical officer for Hazelden, will provide an overview about the epidemiology of the opioid epidemic. During this webinar participants will be educated on how the combination of science and spirituality work together as part of a unique approach to treating opioid addiction, giving patients the best opportunity for long-term recovery.

To register for this event, please click on the link or copy and paste into your browser:

 
 Please read the following important messages before registering for this event:
  • FADAA uses WebEx as our online event system.
  • Audio for the event is accessible via the internet. To receive audio, attendees must join the event by using computers equipped with speakers. There is no teleconference for this event.
  • Once the host approves your registration, you will receive a confirmation email message with instructions on how to join the event. To avoid problems with log-in and receiving credit for attendance, please use the confirmation email to join the event. This email is coded with your registration information. Also, please confirm that email from "MESSENGER@WEBEX.COM" is not blocked as spam or junk by your email server.

     
ABOUT THE
PRESENTER: 
Marvin D. Seppala, M.D., is a graduate of the Mayo Medical School. He completed his psychiatric training and a fellowship in addiction at the University of Minnesota Hospitals in Minneapolis. He is the Chief Medical Officer of the Hazelden Betty Ford Foundation where his responsibilities include overseeing all interdisciplinary clinical practices, maintaining and improving standards of care, and supporting growth strategies for residential and nonresidential addiction treatment programs.  Dr. Seppala is the author of Clinician's Guide to The Twelve Step Principles and co-author of Pain-Free Living for Drug-Free People, and When Painkillers Become Dangerous.He has appeared as a guest on the CBS-TV "Early Show" and National Public Radio. He has been quoted in The New York Times, The Washington Post, USA Today, Newsweek and The Wall Street Journal.



 

This product is supported by Florida Department of Children and Families
Substance Abuse and Mental Health Program Office funding